欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2191/003
药品名称Salmeterol/Flutikason ELC Group
活性成分
    • fluticasone propionate 500.0 µg/dose
    • salmeterol xinafoat 50.0 µg/dose
剂型Inhalation powder, pre-dispensed
上市许可持有人ELC GROUP s.r.o.
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Czechia (CZ)
      Zoreeda Ciphaler 50 mikrogramů/500 mikrogramů dávkovaný prášek k inhalaci
    • Romania (RO)
    • Slovakia (SK)
    • Denmark (DK)
    • Belgium (BE)
      Fullhale Ciphaler 50 microgram/500 microgram/dosis, inhalatiepoeder, voorverdeeld
    • Austria (AT)
    • France (FR)
    • Italy (IT)
    • Norway (NO)
    • Poland (PL)
许可日期2023/01/18
最近更新日期2024/01/26
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase